GSK1940029

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

GSK1940029 是一种硬脂酰辅酶去饱和酶 (SCD) 抑制剂。

GSK1940029 is a stearoyl-coa desaturase (SCD) inhibitor.(In Vitro):GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD), which can be used to treat and/or preventing various diseases, including those mediated by SCD enzyme, such as diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, skin disorders such as acne, diseases or conditions related to cancer and the treatment of symptoms linked to the production of the amyloid plaque-forming Aβ42 peptide such as Alzheimer's disease.

GSK1940029 (SCD inhibitor 1) is a stearoyl-coa desaturase (SCD), which can be used to treat and/or preventing various diseases, including those mediated by SCD enzyme, such as diseases related to elevated lipid levels, cardiovascular disease, diabetes, obesity, metabolic syndrome, skin disorders such as acne, diseases or conditions related to cancer and the treatment of symptoms linked to the production of the amyloid plaque-forming Aβ42 peptide such as Alzheimer's disease.

——

SCD inhibitor 1

Metabolic Enzyme/Protease

Dehydrogenase

SCD

Endocrinology

Acne Vulgaris

1150701-66-8

391.25

C18H16Cl2N4O2

>98% (HPLC)

DMSO:30 mg/mL (76.67 mM)

Cc1c(nnn1Cc1ccc(Cl)c(Cl)c1)C(=O)Nc1ccc(CO)cc1

1-[(34-dichlorophenyl)methyl]-N-[4-(hydroxymethyl)phenyl]-5-methyltriazole-4-carboxamide

(-20℃)

With Ice Pack

≥ 2 years